Plasma/Serum Cell-Free Circulating DNA Purification Kits Dx
For isolating cell-free circulating DNA (cfc-DNA) from plasma/serum for subsequent in vitro diagnostic use
For in vitro diagnostic use. Not available for sale in the United States.
Plasma/Serum Cell-Free Circulating DNA Purification Kits Dx
For isolating cell-free circulating DNA (cfc-DNA) from plasma/serum for subsequent in vitro diagnostic use
Register today to receive an exclusive 15% off* on your first order.
Features and Benefits
- Concentrate circulating DNA into a flexible elution volume ranging from (25 µL - 50 µL)
- Isolate inhibitor-free cell-free circulating DNA
- Compatible with Streck Cell-Free DNA BCT® Tubes
- Purification is based on spin column chromatography that uses Norgen’s proprietary resin separation matrix
- Research use format is also available
These kits provide a fast, reliable and convenient spin column method for the isolation of high quality, high purity and inhibitor-free cell-free circulating DNA (cfc-DNA) from plasma/serum sample. These kits are designed to isolate all sizes of cfc-DNA from either fresh or frozen plasma/serum samples and the purified DNA is eluted into a flexible elution volume ranging from 25 µL to 50 µL. The purified plasma/serum cfc-DNA is fully compatible with all downstream applications including PCR, qPCR, methylation-sensitive PCR and Southern Blot analysis, microarrays and NGS.
Background
Plasma/Serum cell-free circulating DNA (cfc-DNA) has the potential to provide biomarkers for certain cancers and disease states as well as fetal DNA in maternal blood. Currently, significant advancements are being made in utilizing cfc-DNA as biomarkers for the early diagnosis, prognosis and monitoring of therapy for several cancer types and autoimmune diseases. Cell-free mitocondrial DNA (cfmtDNA) is also under investigation for its clinical significance. This cfc-DNA is usually present as short fragments of less than 1000 bp. In addition, cell-free fetal DNA has been widely used as a non-invasive method for prenatal diagnosis including early identification of fetal sex, genetic studies for families at high risk for inherited genetic disorders, screening for Rhesus factor, screening for aneuploidy and identification of preeclampsia.
Plasma/Serum Cell-Free Circulating DNA Purification Micro Kit Dx
For serum input volumes 10 µL - 200 µL. Purify high-quality DNA in 15-20 minutes
Plasma/Serum Cell-Free Circulating DNA Purification Mini Kit Dx
For serum input volumes 200 µL - 500 µL. Purify high-quality DNA in 15-20 minutes.
Plasma/Serum Cell-Free Circulating DNA Purification Midi Kit Dx
The first column will handle the large volume input of bodily fluids that is followed by a concentration on a mini column for a final elution of 25 µL to 50 µL. All components for the purification & concentration are provided in one convenient & fast kit for the easy processing of large input volumes of bodily fluids. For a schematic workflow of the protocol click here to view. For serum input volumes 1 mL - 4 mL. Purify high-quality DNA in 90 minutes.
Plasma/Serum Cell-Free Circulating DNA Purification Maxi Kit Dx
The first column will handle the large volume input of bodily fluids that is followed by a concentration on a mini column for a final elution of 25 µL to 50 µL. All components for the purification & concentration are provided in one convenient & fast kit for the easy processing of large input volumes of bodily fluids. For a schematic workflow of the protocol click here to view. For serum input volumes 5 mL - 10 mL. Two kits in one - purify and concentrate DNA from bodily fluids using a convenient two column system.
Details
Supporting Data
Kit Specifications | |
Minimum Plasma/Serum Input | 10 ÎĽL |
Maximum Plasma/Serum Input | 200 ÎĽL |
Size of DNA Purified | ≥ 50 bp |
Elution Volume | 25-50 ÎĽL |
Time to Complete 10 Purifications | 15-20 minutes |
Average Yields* | Variable depending on specimen |
*Please check page 7 in the product manual for the Plasma/Serum Average Yields and the Common DNA Quantification Methods.
Storage Conditions and Product Stability
All buffers should be kept tightly sealed and stored at room temperature (15-25°C) for up to 2 years without showing any reduction in performance. Norgen's Plasma/Serum Cell-Free Circulating DNA Purification Kits contain ready-to-use Proteinase K solution, which is dissolved in a specially prepared storage buffer. The Proteinase K is stable for up to 2.5 years after delivery when stored at room temperature. To prolong the lifetime of Proteinase K, storage at 2–8°C is recommended.
Component | Cat. Dx55100 (50 preps) | Cat. Dx55500 (50 preps) | Cat. Dx55600 (20 preps) | Cat. Dx55800 (10 preps) |
---|---|---|---|---|
Binding Buffer B | 2 x 40 mL | 40 mL | 2 x 85 mL 1 x 12 mL |
2 x 85 mL 1 x 40 mL |
Proteinase K | 2 x 1 mL | 0.6 mL | 6.5 mL | 8 mL |
Solution WN | 18 mL | 18 mL | 18 mL | 18 mL |
Wash Solution A | 38 mL | 18 mL | 18 mL | 18 mL |
Elution Buffer B | 8 mL | 8 mL | 30 mL | 30 mL |
Micro Spin Columns | 50 | 50 | 20 | 10 |
Mini Spin Columns | 50 | - | - | - |
Midi Spin Columns | - | - | 20 | - |
Maxi Spin Columns | - | - | - | 10 |
Collection Tubes | 100 | 50 | 20 | 10 |
Elution Tubes (1.7 mL) | 100 | 50 | 20 | 10 |
Product Insert | 1 | 1 | 1 | 1 |
Documentation
(Dx55100) Plasma/Serum Cell-Free Circulating DNA Purification Mini Kit Dx - Protocol (50 prep)
(Dx55600) Plasma/Serum Cell-Free Circulating DNA Purification Midi Kit Dx - Protocol (20 prep)
(Dx55800) Plasma/Serum Cell-Free Circulating DNA Purification Maxi Kit Dx - Protocol (10 prep)
Dx55100 - Plasma/Serum Cell-Free Circulating DNA Purification Mini Kit Dx - SDS
Dx55600 - Plasma/Serum Cell-Free Circulating DNA Purification Midi Kit Dx - SDS
Dx55800 - Plasma/Serum Cell-Free Circulating DNA Purification Maxi Kit Dx - SDS
Citations
Micro (Dx55500)
Title | Evaluation of commercial kits for purification of circulating free DNA |
Journal | Cancer Genetics. 2019. |
Authors | Russell J. Diefenbach, Jenny H. Lee, Richard F. Kefford, Helen Rizos, |
Title | Enzyme-Powered Three-Dimensional DNA Nanomachine for DNA Walking, Payload Release, and Biosensing |
Journal | ACS Nano. 2016. |
Authors | Yang, X., Tang, Y., Mason, S. D., Chen, J., & Li, F |
Mini (Dx55100)
Title | Evaluation of commercial kits for purification of circulating free DNA |
Journal | Cancer Genetics. 2019. |
Authors | Russell J. Diefenbach, Jenny H. Lee, Richard F. Kefford, Helen Rizos, |
Title | 554P KRAS-dependent and independent mechanisms of progressive disease (PD) in colorectal cancer (CRC) patients (pts) with liver metastases (LM) while monitoring on circulating cell free DNA (cfDNA) |
Journal | Annals of Oncology. October 23, 2018. |
Authors | A Kirov Z Mihaylova, V Petrova, T Todorov, D Petkova, A Garev, A Todorova-Georgieva |
Title | Advances in Circulating Tumor DNA Analysis |
Journal | Advances in Clinical Chemistry. 2017. |
Authors | S. Perakis, M. Auer, J. Belic, E. Heitzer |
Title | Comprehensive evaluation of methods to isolate, quantify, and characterize circulating cell-free DNA from small volumes of plasma |
Journal | Analytical and Bioanalytical Chemistry. 2015. |
Authors | Mauger F, Dulary C, Daviaud C, Deleuze JF, Tost J. |
Midi (Cat. Dx55600)
Title | Evaluation of commercial kits for purification of circulating free DNA |
Journal | Cancer Genetics. 2019. |
Authors | Russell J. Diefenbach, Jenny H. Lee, Richard F. Kefford, Helen Rizos, |
Maxi kit (Dx55800)
Title | Evaluation of commercial kits for purification of circulating free DNA |
Journal | Cancer Genetics. 2019. |
Authors | Russell J. Diefenbach, Jenny H. Lee, Richard F. Kefford, Helen Rizos, |